These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19743411)

  • 1. Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins.
    Yang G; Li Q; Ren S; Lu X; Fang L; Zhou W; Zhang F; Xu F; Zhang Z; Zeng R; Lottspeich F; Chen Z
    Proteomics; 2009 Nov; 9(21):4944-61. PubMed ID: 19743411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of ZO-1/2 as a novel scaffold for Src/Csk regulatory circuit.
    Saito K; Enya K; Oneyama C; Hikita T; Okada M
    Biochem Biophys Res Commun; 2008 Feb; 366(4):969-75. PubMed ID: 18086565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSK associates with the TCR zeta and epsilon chains via its SH2 domain; a mechanism for turning off TCR signaling.
    Catipović B
    Lijec Vjesn; 1996; 118(11-12):264-71. PubMed ID: 9172452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling.
    Wang Y; Du D; Fang L; Yang G; Zhang C; Zeng R; Ullrich A; Lottspeich F; Chen Z
    EMBO J; 2006 Nov; 25(21):5058-70. PubMed ID: 17053785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of protease-activated receptor 1-induced Src kinase activity by the association of phosphocaveolin-1 with Csk.
    Lu TL; Kuo FT; Lu TJ; Hsu CY; Fu HW
    Cell Signal; 2006 Nov; 18(11):1977-87. PubMed ID: 16678999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
    Sayós J; Martínez-Barriocanal A; Kitzig F; Bellón T; López-Botet M
    Biochem Biophys Res Commun; 2004 Nov; 324(2):640-7. PubMed ID: 15474475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.